The recent judgement of the Court of Justice of the European Union (“CJEU”) on the sale of over-the-counter (OTC) medicinal products online (C-606/21, decision published on 29.02.2024) may have a direct impact on the existing Hungarian legislation and established market practice.
Case summary
The Union des Groupements de pharmaciens d’officine (UDGPO) challenged the legality of the services provided by Doctipharma, an online platform provider facilitating the sale of OTC medicines from pharmacy websites liked to its platform. The Union argued that by providing a service through its platform, Doctipharma was involved in the online sale of medicinal products and violated French legislation prohibiting the sale of medicinal products by unqualified persons.
The Court clarified that Doctipharma’s service constituted an “information society service” under EU law, connecting dispensing pharmacists and potential patients through the service of selling OTC medicines.
The Court differentiated two scenarios:
- it concluded that a Member State can prohibit the provision of services, if a service provider lacking the pharmacist’s qualification, intends to sell OTC medicines on their own,
- it concluded that if the service provider merely facilitated connections between sellers and customers, without engaging in direct sales, Member States cannot prohibit the provision of services even if the service provider lacks the pharmacist’s qualification.
The Court finally concluded that Member States have the authority to regulate who can sell OTC medicines online but should also allow online sales through a third party that solely facilitates connections between sellers and customers.
Online sales in Hungary
In Hungary, only pharmacies are legally allowed to conduct online sales of OTC medicines, and are required to inform the Hungarian pharmaceutical authority of their website prior to commencing operations.
Online platform providers can facilitate the sale of OTC medicines, but due to the recently tightened rules involving home delivery, they can only sell the aforementioned products; customers need to pick-up their orders at the pharmacy. In practice, this means that the sale of these products by online platform providers is rather limited, if it exists at all. Therefore, the question is whether the rules regarding home delivery in Hungary can be considered compatible with the EU law, in light of the CJEU’s decision.
For further information on the Hungarian pharmaceutical industry, contact Miriam Fuchs or Lilla Lantai at the Wolf Theiss office in Budapest.
Life Sciences Bulletin: CJEU ruling on the online sale of OTC medicines may impact Hungarian market
The recent judgement of the Court of Justice of the European Union (“CJEU”) on the sale of over-the-counter (OTC) medicinal products online (C-606/21, decision published on 29.02.2024) may have a direct impact on the existing Hungarian legislation and established market practice. Case summary The Union des Groupements de pharmaciens d’officine (UDGPO) challenged the legality of […]...
Digital Law: Putting the AI Act into practice
Our new episode of the Wolf Theiss Soundshot Podcast is the third one in our “Digital Law” series. In this episode, Jakub Pietrasik and Phillip Wrabetz from our IP & TMT team discuss the recently adopted EU Artificial Intelligence Act and how businesses should already begin preparing for the new legal framework. The AI Act […]...
Wolf Theiss advised Volksbank Wien AG on its issue of EUR 500,000,000 Subordinated Notes (Tier 2)
Vienna, 27 March 2024 – Wolf Theiss comprehensively advised VOLKSBANK WIEN AG as Issuer on its issue of “EUR 500.000.000 5.750% Fixed to Fixed 10.25NC5.25 Subordinated Notes (Tier 2) with an Interest Rate Change Date on 21 June 2029” (AT000B122270). VOLKSBANK WIEN AG successfully completed the issue of EUR 500 million Tier 2 notes. The notes have […]...
Medicine shortages in the CEE & SEE
Medicine shortages in Europe have reached unprecedented levels as a result of the COVID-19 pandemic. While this topic has been a concern for stakeholders and regulators for decades, the post-pandemic crisis necessitated urgent legislative reforms by individual countries and the European Union to meet pressing demands. The CEE&SEE region, which has traditionally faced high levels […]...
Wolf Theiss facilitates Allianz Bank Bulgaria’s strategic partnership with European Investment Bank Group, boosting SME lending capacity
Sofia, 22 March 2024 – Wolf Theiss provided support to Allianz Bank Bulgaria in the review, negotiations and regulatory compliance of a Synthetic Securitization Agreement with the European Investment Bank Group. The execution of the agreement was announced by EIF, EIB and Allianz Bank Bulgaria at the end of February 2024. This arrangement allows Allianz […]...
AI Act – New rules for tech companies
The adoption of the Artificial Intelligence Act means a wide range of responsibilities for tech businesses in the European Union. This article guides through the new regulatory framework and its practical implications. On 13 March 2024, the European Parliament adopted the AI Act – landmark EU legislation comprehensively addressing all issues connected with the regulatory […]...
Soziale Beschaffungen
In dieser Folge unseres Vergaberecht-Podcasts diskutieren Manfred Essletzbichler und Wolfgang Lauchner das Thema “Soziale Beschaffungen”. Unsere Vergabeexperten besprechen die Herausforderungen im Pflege- und Betreuungsbereich aufgrund des demografischen Wandels und Fachkräftemangels sowie die vergaberechtliche Umsetzung möglicher Lösungsansätze wie Übergangspflege und Community-Nurse-Konzepte (unter Berücksichtigung der speziellen “Spielregeln” für die Vergabe “sozialer Dienstleistungen” und die Beauftragung gemeinnütziger Organisationen). […]...
ESG in Bulgaria – Five Factors to Watch in 2024
One of the significant questions concerning ESG issues is the cost of transitioning to a more sustainable business environment. Will it result in increased financing costs and restricted access to new borrowing, or will it, on the contrary, lead to the development of new market segments and gradual change? While we cannot provide definitive answers […]...
Beware of the phishing bait. Don’t get hooked!
In today’s digital landscape, cyber-attacks such as phishing attacks have become more sophisticated than ever. We welcome you to join us and create together the space for a lively and active discussion around this hot topic on Tuesday, 26 March 2024, from 9:30 a.m., at our headquarters in Bucharest, 4 Vasile Alecsandri Street, The Landmark, […]...
Recent changes in Hungarian e-commerce and consumer protection regulations
Since early 2024, Hungarian legislative efforts have brought about several updates to consumer protection regulations. Ranging from novelties in consumer complaints and related processes, increased consumer protections fines, expanded rights of the consumer protection and competition authority to an unexpected obligation imposed on e-commerce providers to include the local postal delivery provider as a delivery […]...
International arbitration in CEE & SEE
Wolf Theiss’ strength has always been its regional coverage and we believe this is particularly true for our arbitration team. The Wolf Theiss Regional Arbitration Team consists of experts across our 13 offices in Central, Eastern and Southeastern Europe (CEE/SEE) acting as counsel in domestic and international arbitration proceedings. Additionally, several team members have specialized […]...
Hungarian legislation reform related to centralised procurement for institutional pharmacies
The governmental decree published on 22 February (No. 33/2024 (II. 22.)) sets forth the establishment of a new project company to manage the provision of inpatient pharmaceuticals in all public hospitals, as well as those private hospitals that choose to join the initiative. The Decree is a follow up to the amendments in the Medicines […]...